Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201310115 Principal Investigator: Ghobadi, Armin
Title: A Phase 3, Randomized, Open Label Study Investigating the Efficacy of the BiTE Antibody Blinatumomab Versus Standard of Care Chemotherapy in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (TOWER Study)
Phase: III Disease Site: Lymphoid Leukemia
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
This study will compare blinatumomab to the standard of care chemotherapy that patients would normally receive to find out which treatment works best to treat Philadelphia negative Acute Lymphoblastic Leukemia.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)